🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to assess the efficacy and safety of ruxolitini...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2021-07-19
Trial ID
NCT04921969
Treatments Being Tested
This is a global, multicenter, 2-part study to evaluate the efficacy and sa...
Status
Active Not Recruiting
Location
UAB Division of Hematology/Oncology
Start Date
2021-03-11
Trial ID
NCT04562389
Treatments Being Tested
The purpose of this study was to determine if ruxolitinib, in combination w...
Status
Terminated
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02119676
Treatments Being Tested
The purpose of this trial is to evaluate whether treatment with pelabresib ...
Status
Recruiting
Location
Yale University School Of Medicine
Start Date
2026-06-08
Trial ID
NCT07357727
Treatments Being Tested
This was a randomized, double-blind, placebo-controlled phase 2 clinical tr...
Status
Terminated
Location
Multiple Locations
Start Date
2014-05
Trial ID
NCT02120417
Treatments Being Tested
A Phase 3, randomized, blinded study comparing pelabresib (CPI-0610) and ru...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2021-04-09
Trial ID
NCT04603495
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of ruxolit...
Status
Terminated
Location
Honor Health Research Institute
Start Date
2020-05-24
Trial ID
NCT04377620
Treatments Being Tested
This was to determine the efficacy, based upon overall survival, of ruxolit...
Status
Terminated
Location
Multiple Locations
Start Date
2014-06
Trial ID
NCT02119663
Treatments Being Tested
The purpose of this study was to determine if ruxolitinib, in combination w...
Status
Terminated
Location
Multiple Locations
Start Date
2014-02-11
Trial ID
NCT02119650
Treatments Being Tested
The purpose of the study is to assess the efficacy and safety of ruxolitini...
Status
Active Not Recruiting
Location
Clinical Research Center of Alabama
Start Date
2025-06-17
Trial ID
NCT06832618
Treatments Being Tested